Astrana Health Inc (ASTH)
38.88
-1.16
(-2.90%)
USD |
NASDAQ |
Jun 13, 16:00
38.86
-0.02
(-0.05%)
Pre-Market: 20:00
Astrana Health Cash from Financing (Quarterly): 106.35M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 106.35M |
| December 31, 2023 | 11.99M |
| September 30, 2023 | -0.51M |
| June 30, 2023 | -0.963M |
| March 31, 2023 | -7.099M |
| December 31, 2022 | 5.871M |
| September 30, 2022 | -6.251M |
| June 30, 2022 | -20.24M |
| March 31, 2022 | 0.532M |
| December 31, 2021 | 1.435M |
| September 30, 2021 | -11.02M |
| June 30, 2021 | -39.43M |
| March 31, 2021 | 1.262M |
| December 31, 2020 | 0.647M |
| September 30, 2020 | -21.80M |
| June 30, 2020 | -18.49M |
| March 31, 2020 | -12.06M |
| December 31, 2019 | -10.38M |
| September 30, 2019 | 152.08M |
| June 30, 2019 | 31.44M |
| March 31, 2019 | -9.81M |
| December 31, 2018 | -5.803M |
| September 30, 2018 | -3.642M |
| June 30, 2018 | -1.490M |
| March 31, 2018 | -0.2412M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0855M |
| June 30, 2017 | -0.0375M |
| March 31, 2017 | 9.507M |
| December 31, 2016 | 0.283M |
| September 30, 2016 | -0.535M |
| June 30, 2016 | -0.3305M |
| March 31, 2016 | 4.717M |
| December 31, 2015 | 2.343M |
| September 30, 2015 | -0.1225M |
| June 30, 2015 | -0.5954M |
| March 31, 2015 | -0.4875M |
| December 31, 2014 | 0.9386M |
| September 30, 2014 | 1.379M |
| June 30, 2014 | -0.175M |
| January 31, 2014 | 1.148M |
| October 31, 2013 | 0.4924M |
| July 31, 2013 | -0.0032M |
| April 30, 2013 | 0.389M |
| January 31, 2013 | 0.9111M |
| October 31, 2012 | -0.095M |
| July 31, 2012 | 0.00 |
| April 30, 2012 | 0.17M |
| January 31, 2012 | 0.00 |
| October 31, 2011 | -0.0043M |
| July 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-39.43M
Minimum
Jun 2021
152.08M
Maximum
Sep 2019
8.169M
Average
-0.7365M
Median
Cash from Financing (Quarterly) Benchmarks
| American Shared Hospital Services | 2.282M |
| Novo Integrated Sciences Inc | 0.0032M |
| Cryo-Cell International Inc | 0.539M |
| P3 Health Partners Inc | 11.40M |
| Biote Corp | -5.409M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.977M |
| Cash from Investing (Quarterly) | -71.04M |
| Free Cash Flow | 52.44M |
| Free Cash Flow Per Share (Quarterly) | 0.1176 |
| Free Cash Flow to Equity (Quarterly) | -105.15M |
| Free Cash Flow to Firm (Quarterly) | 8.129M |
| Free Cash Flow Yield | 2.86% |